We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2013 by Rothman Institute Orthopaedics.
Recruitment status was:  Recruiting
ClinicalTrials.gov Identifier:
First Posted: June 7, 2012
Last Update Posted: April 9, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Rothman Institute Orthopaedics
This study aims to investigate short-term outcomes following the use of two femoral stems used during Total Hip arthoplasty: the Fitmore Femoral stem and the M/L Taper Femoral stem.

Condition Intervention
Total Hip Arthroplasty Procedure: Total Hip Arthoplasty

Study Type: Interventional

Further study details as provided by Rothman Institute Orthopaedics:

Primary Outcome Measures:
  • Short term hip function [ Time Frame: within six weeks post-operative ]
    Early functional outcome will be measured using the modified Harris Hip score at the first post-operative visit

Secondary Outcome Measures:
  • Short-Term Pain Levels of direct anterior and anterolateral surgical approaches
    Short-term (6 weeks post-op) pain will also be compared between the approach used for the total hip replacement: namely direct anterior and anterolateral using a VAS pain scale

Arms Assigned Interventions
Active Comparator: Total Hip Arthroplasty using Fitmore femoral stem Procedure: Total Hip Arthoplasty
Active Comparator: Total Hip Arthroplasty using M/L Taper Femoral stem Procedure: Total Hip Arthoplasty


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient signed an IRB, study specific informed patient consent.
  • Patient is a male or non-pregnant female age 18 years or older at the time of study device implantation.
  • Patient has primary diagnosis of non-inflammatory degenerative joint disease.
  • Patient is a candidate for primary cementless total hip replacement.
  • Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion Criteria:

  • Patient has a Body Mass Index (BMI) > 40 Kg/m2.
  • Patient has an active or suspected infection at the time of device implantation.
  • Patient is immunologically suppressed.
  • Patient requires revision surgery of a previously implanted total hip replacement.
  • Patient has a known sensitivity to device materials.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01614028

United States, New Jersey
Rothman Institute at AtlantiCare Recruiting
Egg Harbor Township, New Jersey, United States, 08234
Contact: Anne Marie Madden, CCRP    609-407-6446      
Sub-Investigator: Zachary Post, MD         
Sub-Investigator: Alvin Ong, MD         
Sub-Investigator: Fabio Orozco, MD         
United States, Pennsylvania
Rothman Institute at Thomas Jefferson University Recruiting
Philadelphia, Pennsylvania, United States, 19107
Contact: Tiffany Morrison, MS, CCRP    267-339-7818      
Principal Investigator: Gregory Deirmengian, MD         
Sub-Investigator: Javad Parvizi, MD         
Sponsors and Collaborators
Rothman Institute Orthopaedics
  More Information

Responsible Party: Rothman Institute Orthopaedics
ClinicalTrials.gov Identifier: NCT01614028     History of Changes
Other Study ID Numbers: JP2012-01
First Submitted: June 4, 2012
First Posted: June 7, 2012
Last Update Posted: April 9, 2013
Last Verified: April 2013